We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+0.21%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
AUM
$296M
AUM Growth
-$4.31M
Cap. Flow
+$86.6K
Cap. Flow %
0.03%
Top 10 Hldgs %
47.38%
Holding
588
New
23
Increased
63
Reduced
57
Closed
32

Sector Composition

Rank Sector Weight
1 Technology 52.09%
2 Healthcare 7.88%
3 Consumer Staples 6.24%
4 Industrials 5.95%
5 Financials 5.01%

No holdings matched the selected filter criteria.

Similar funds

Front Row Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, Front Row Advisors held 588 positions worth $296M, down 1.4% from $300M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Front Row Advisors's Q1 2026 filing shows 23 new, 63 increased, 57 reduced and 32 closed positions. Its largest new stake was Blackstone: 500 shares worth $57.5K. The largest sale was NVIDIA, an estimated $466K.

By sector, the portfolio is most concentrated in Technology at 52% of assets, down from 53% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Front Row Advisors's largest Q1 2026 buy was Blackstone: 500 shares worth $57.5K.
  • Front Row Advisors added most to Arbutus Biopharma in Q1 2026, an estimated $437K increase.
  • Front Row Advisors's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $466K.
  • Front Row Advisors fully exited Confluent in Q1 2026, selling an estimated $24.2K.
  • Front Row Advisors's ten largest holdings make up 47% of its $296M portfolio in Q1 2026.
  • Front Row Advisors opened 23 new positions and closed 32 in Q1 2026.
  • Front Row Advisors's portfolio value fell 1.4% quarter-over-quarter to $296M.

Based on Front Row Advisors's 13F filing for Q1 2026, filed 19 May 2026.